OrthogenRx

OrthogenRx is a commercial-stage product development company that provides orthopedic medical devices for the treatment of musculoskeletal conditions. The business model utilizes exclusive supply and license agreements for products presently on the market ex-US and seeks generic product approval in the U.S. potentially saving the healthcare system billions in cost. The strategy utilizes existing regulations for an abbreviated regulatory approval for generic devices, analogous to generic drugs.

OrthogenRx headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device, Commercial sector. The company focuses on Biotechnology and has secured $521.0M in funding across 80 round(s). With a team of 11-50 employees, OrthogenRx is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - OrthogenRx, raised $1.3M. Discover more about their projects, partnerships, and impact on our platform.